Concepedia

Arindom Pal

AP

10

Publications

486

Citations

10

H-Index

2013

Active since

Affiliations

Johns Hopkins Medicine(Current)

Johns Hopkins University

University of the Pacific

Arindom Pal is an author at Johns Hopkins Medicine specializing in pharmacology, medicine, and drug discovery.

ORCID

Top concepts

Publications per year

2013–2023

10

Publications

10

A biomimetic approach for enhancing the in vivo half-life of peptides

Sravan Penchala, Mark R. Miller, Arindom Pal et al. · Nature Chemical Biology · 2015 · 132 citations · Full text

, , +10

Discovery of DRP-104, a tumor-targeted metabolic inhibitor prodrug

Rana Rais, Kathryn M. Lemberg, Lukáš Tenora et al. · Science Advances · 2022 · 110 citations · Full text

Enthalpy-Driven Stabilization of Transthyretin by AG10 Mimics a Naturally Occurring Genetic Variant That Protects from Transthyretin Amyloidosis

Mark R. Miller, Arindom Pal, Wabel Albusairi et al. · Journal of Medicinal Chemistry · 2018 · 93 citations · Full text

Inhibition of neutral sphingomyelinase 2 reduces extracellular vesicle release from neurons, oligodendrocytes, and activated microglial cells following acute brain injury

Carolyn Tallon, Silvia Picciolini, Seung‐Wan Yoo et al. · Biochemical Pharmacology · 2021 · 37 citations · Full text

, , +13

Hydrophilic Small Molecules That Harness Transthyretin To Enhance the Safety and Efficacy of Targeted Chemotherapeutic Agents

Arindom Pal, Wabel Albusairi, Fang Liu et al. · Molecular Pharmaceutics · 2019 · 26 citations · Full text

, , +14

Rows per page

1–5 of 10